Physician profile
Michael Patrick Collini
NPI 1801882329
$7,588.88
in general payments reported to CMS, 2019-2025
37 companies · $490 in 2025
The $490 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $1,670 · 2021: $1,300 · 2022: $1,204 · 2023: $714 · 2024: $635 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,725 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,724.58 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,171.23 | 2019-2022 | |
| Medtronic USA, INC. | $1,135.05 | 2019-2020 | |
| Janssen Biotech, INC. | $767.71 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $519.86 | 2019-2022 | |
| Myovant Sciences INC. | $404.82 | 2021-2022 | |
| Abbvie INC. | $383.62 | 2019-2023 | Lupron Depot |
| Dendreon Pharmaceuticals LLC | $357.93 | 2019-2023 | Provenge |
| Kerecis Limited | $224.02 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $191.84 | 2023 | Interstim |
| Teleflex LLC | $176.75 | 2021-2023 | Urolift |
| Olympus America INC. | $174.24 | 2024-2025 | Itind System |
| Axonics, INC. | $173.54 | 2022-2024 | Bulkamid |
| Urogen Pharma, INC. | $167.89 | 2020-2025 | Jelmyto |
| Blue Earth Diagnostics | $167.78 | 2019-2022 | |
| Procept Biorobotics Corporation | $154.55 | 2021-2025 | Aquabeam System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $153.28 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $137.77 | 2020-2022 | |
| Healthtronics Stone Solutions, LLC | $117.16 | 2022-2024 | Dornier Medtech |
| Intuitive Surgical, INC. | $113.16 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $101.75 | 2020-2024 | |
| Coloplast Corp | $100.99 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $98.48 | 2019 | |
| Sun Pharmaceutical Industries INC. | $97.93 | 2022-2023 | Yonsa |
| C. R. Bard, INC. & Subsidiaries | $95.37 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $67.81 | 2023 | Orgovyx |
| Urovant Sciences INC | $66.28 | 2021-2022 | |
| Accord Healthcare, INC. | $56.74 | 2022 | |
| Bioprotect Medical, INC. | $39.00 | 2024 | Bioprotect Balloon Implant System |
| Neotract INC. | $32.34 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $31.92 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $21.79 | 2022 | |
| Pfizer INC. | $19.41 | 2022 | |
| Travere Therapeutics, INC. | $18.93 | 2021 | |
| Mission Pharmacal Company | $18.34 | 2019 | |
| Myriad Genetic Laboratories, INC. | $15.66 | 2022 | |
| Ethicon US, LLC | $13.94 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Collini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.